A 65-year-old male patient with nephrotic syndrome was admitted to our hospital due to worsening systemic edema and purpura on the limbs. He had an impaired renal function, low serum complement level, and elevated rheumatoid factor level. He was positive for cryoglobulin (monoclonal IgM-κ and polyclonal mixed-type IgG), and the results of his kidney biopsy showed a tissue profile of membranoproliferative glomerulonephritis (MPGN). Due to the fact that the secondary cause was unclear, he was diagnosed with MPGN due to essential mixed cryoglobulinemia. On hospital day 20, he was initiated on 50 mg/day prednisolone (PSL). On hospital day 43, oral mizoribine (MZR) at a dose of 150 mg/day was prescribed. On hospital day 49, cryofiltration was performed because the disease was steroid resistant. The treatment promptly decreased urine protein levels. Serum albumin and serum complement levels increased, and complete remission was achieved approximately three months after the initiation of treatment. The PSL and MZR doses were gradually reduced to 2 mg/day and 100 mg/ day, respectively, without any reemergence of the symptoms of cryoglobulinemia or relapse of the nephrotic syndrome for three years. Here, we report this case with essential mixed cryoglobulinemia in whom we could achieve complete remission of the disease by adding cryofiltration to the oral corticosteroid and immunosuppressant therapy with mizoribine and could maintain for a long time.
Introduction
Approximately, 90% of cases with mixed cryoglobulinemia are related to hepatitis C infection. Cases of essential mixed cryoglobulinemia, with unknown underlying disease, are rare, accounting for approximately 5% of all cases [1] . Approximately, 55% and 20% of patients with essential mixed cryoglobulinemia have been reported to develop renal impairment and nephrotic syndromes, respectively.
Currently, this disease has no well-established therapy and its 10-year survival rate is 49% [2] . It has been shown in a report that this 10-year survival rate has significantly improved to 65% using corticosteroid drugs, immunosuppression, and plasma exchange [3] ; however, these therapies have not yet been established for essential mixed cryoglobulinemia. We report here a case of a patient with membranoproliferative glomerulonephritis (MPGN) due to essential mixed cryoglobulinemia, who achieved long-term complete remission by immunosuppressant therapy with mizoribine (MZR) and cryofiltration in addition to a corticosteroid drug.
Case report
A 65-year-old male patient had been well until several weeks before admission, when he found edema of his face and lower legs with 8 kg weight gain in two weeks. Chest 
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X-ray showed a dilated cardiothoracic ratio and pleural effusion, and he was admitted to a local hospital. The symptoms improved with diet therapy (NaCl 5 g/day) and administration of diuretics, and he was discharged. After two months, low-grade fever persisted, and purpura appeared on all of his limbs. He had elevated levels of inflammatory reaction and rheumatoid factor (RF), and he was positive for antinuclear antibodies. Skin biopsy was performed to investigate the purpura, but the findings were nonspecific. Several weeks later, the facial and bilateral lower leg edema aggravated, and urinalysis revealed urinary protein excretion of approximately 6.8 g/gCr and 2 + hematuria, and the sediment contained 30-49 red blood cells and 1-4 white blood cells per high-power field, as well as various types of casts. Renal function deteriorated with serum creatinine of 2.13 from 1.09 mg/dL. He was hospitalized at our university hospital.
History of past diseases
The patient had pulmonary tuberculosis when he was 13 years old and hypertension when he was 64 years old.
History of smoking and alcohol consumption
The patient has been smoking 10 cigarettes per day for 40 years and consumed approximately 180 mL of shōchū (a distilled spirit) per day.
Oral drugs per day at admission
The patient was given 40 mg of Olmesartan, 10 mg of amlodipine, 80 mg of furosemide, 25 mg of spironolactone, and 100 mg of ferrous citrate.
Physical condition at admission
The patient's height was 163.0 cm, weight 62.4 kg, temperature 36.6 °C, blood pressure 146/73 mmHg, and pulse 60 beats/min, with pale palpebral conjunctiva. He had purpura on the joints of the right hand and the lower legs, as well as prominent lower leg edema. No distinct neurological abnormality was noticed.
Laboratory findings at admission (Table 1)
Urinalysis results showed that the patient showed 3 + both for proteinuria and for urine occult blood and the presence of various types of casts. The 24 h urinary protein excretion was 3.63 g/day, and the serum albumin level was 2.99 g/ dL. The selectivity index was low at 0.31. The levels of urea nitrogen and serum creatinine were 33.1 mg/dL and 2.00 mg/dL, respectively, indicating advanced impairment of renal function. Severe anemia at hemoglobin of 6.0 g/dL was detected and the platelet count was low, at 9.4 × 10 4 µL. Immunological tests showed elevated IgM levels at 1309 mg/ dL and decreased complement levels of C3 and C4 at 46 mg/ dL and 3 mg/dL, respectively. Serum and urine immunoelectrophoresis revealed monoclonal IgM-κ monoclonal protein and polyclonal IgG, but histological examination of the bone marrow showed normocellular bone marrow. The rheumatoid arthritis particle agglutination (RAPA) titer, RF level, and antinuclear antibody titer were 1280, 2441 U/mL, and 2560, respectively. The patient was negative for antibodies of various connective tissue diseases. He had hepatitis B surface antigen at 0.01 IU/mL and he tested negative for hepatitis C virus (HCV) antibody, which ruled out hepatitis B and C infections. The patient's serum was negative for Mycoplasma, cytomegalovirus, Epstein-Barr virus, and Group A β-hemolytic streptococci. Cryoglobulin was positive in the qualitative cryoglobulin test. A large amount of precipitate was formed at 4 °C, which redissolved at 37 °C (Fig. 1 ).
Image analysis findings at admission
Chest X-rays showed cardiomegaly and bilateral pleural effusion. Abdominal ultrasonography showed bilateral enlargement of the kidneys, with the right and left kidneys measuring 11.7 × 5.0 cm and 12.7 × 5.2 cm, respectively. However, whole-body computed tomography scans did not show any lymph node enlargement or splenomegaly.
Kidney biopsy findings (hospital day 8)
The renal biopsy specimen included only the renal cortex, with 32 glomeruli. The glomeruli showed lobulation and duplication of the basement membrane, an increase in the mesangial matrix, and proliferation of mesangial cells Figure 3 shows the clinical course of the patient after admission. The patient was diagnosed with MPGN according to the pathologic findings. The cause of the MPGN seemed to be type II essential mixed cryoglobulinemia. Treatment with prednisolone (PSL) 50 mg/day was started on hospital day 20. Although the urine protein levels decreased temporarily with this treatment, they increased again. Thus, we added MZR 150 mg/day from hospital day 43, and cryofiltration was started once a week on hospital day 49. A Plasauto iQ21 (Asahi Kasei Corp., Tokyo, Japan) was used for the cryofiltration. Plasmaflo OP-08 (Asahi Kasei Corp.) was fitted as the plasma filtration membrane, Cascadeflo EC-50 W (Asahi Kasei Corp.) was fitted as the plasma component separation membrane, a dedicated circuit DFPP-21 (Asahi Kasei Corp.) was fitted as the blood circuit, and a coiled tube that was ice cooled to 0-4 °C was fitted to the plasma outlet. At the start of the filtration, 2000 units of heparin Na were injected intravenously as an anticoagulant, and 1000 units were administered hourly as maintenance. The vascular access was through the femoral vein for removing blood from the patient and the median cubital vein for returning the blood to the patient. Approximately, 2000-3000 mL of plasma was treated per session. Clogging during cryofiltration became progressively less as the sessions of cryofiltration progressed. The cryocrit was 16.5% before cryofiltration and decreased to 2.0% after four rounds of cryofiltration (Fig. 4) . After cryofiltration, the IgG and IgM immunoglobulin levels decreased to 214 mg/dL and 296 mg/dL, respectively, which subsequently showed a gradual improvement. Because urine protein levels rapidly decreased to 0.72 g/day (incomplete remission) and the serum albumin and complement levels increased, cryofiltration was discontinued at the fifth session. The serum level of MZR was 3.78 µg/mL. Therefore, the patient was discharged on hospital day 88. One month after the discharge, the patient showed complete remission, with urinary protein excretion of 0.27 g/gCr/day. Currently, three years after the disease onset, the PSL and MZR doses have been gradually reduced to 2 mg/day and 100 mg/day, respectively. Currently, his serum creatinine and serum albumin levels are 1.49 mg/dL and 3.80 g/dL, respectively, and urinary protein excretion is 0.19 g/gCr/day. As for the complements, C3 has increased to 69 mg/dL, but C4 remains low at 5 mg/dL. 
Clinical course

Discussion
In this case, we could achieve long-term complete remission of MPGN caused by essential mixed cryoglobulinemia using MZR and cryofiltration combined with a corticosteroid drug. Cryoglobulinemia is classified into three types: monoclonal (type I), mixed (polyclonal and monoclonal, type II), and multipolyclonal (with two polyclones, type III). Type I develops after lymphoproliferative diseases, such as multiple myeloma, primary macroglobulinemia, and malignant lymphoma. Approximately, 19% of cases with type II cryoglobulinemia occur after hepatitis C infection, and type III often develops when an underlying connective tissue disease or chronic inflammation is present. Essential mixed cryoglobulinemia with an unknown underlying disease is very rare, accounting for approximately 5% of the cases [1] . Cryoglobulinemic glomerulonephritis is caused by intracapillary, capillary wall (often subendothelial), and mesangial cryoglobulin deposits, giving an MPGN pattern of injury. Patients develop nephritic/ nephrotic syndromes with various levels of kidney function [4] . MPGN is one of the most common causes of nephrotic syndromes in both children and adults [5, 6] . In the Japan Renal Biopsy Registry from 2007 to 2015, 261 out of 593 patients were registered as "secondary" MPGN, including 32 patients with cryoglobulinemia [7] . Age ≥ 50 years, purpura, splenomegaly, Cre > 1.5 mg/dL, IgG < 800 mg/dL, C3 < 54 mg/dL, and cryocrit > 10% have been listed as prognostic determining factors for essential mixed cryoglobulinemia [2] . In addition, a severity score based on peripheral neuropathy, cutaneous symptoms, vasculitis, peripheral ischemia, and joint symptoms has also been reported [8] . The present case seems to belong to the severe category, considering the age, purpura, elevated Cre level, decreased C3 level, and high cryocrit.
Essential cryoglobulinemia has no established treatment. Generally, a corticosteroid drug, immunosuppressant therapy, and plasmapheresis are used in combination [9, 10] . In plasmapheresis for type I cryoglobulinemia, simple plasma exchange is basically performed because the immunoglobulins to be removed are relatively abundant. Alternatively, plasmapheresis using a secondary membrane and cryofiltration can also be employed. The amount of cryoglobulin is relatively less, and its molecular weight is large in types II and III. Therefore, they can be efficiently removed even by plasmapheresis using a secondary membrane with a relatively large pore size, which is generally used to remove IgM. Cryofiltration can also be used. The cryofiltration method used in the present case was developed by Nose and his group in 1980 [11] . It is a modification of double-filtration plasma exchange, where the plasma separated by the membrane is cooled down to precipitate the cryoglobulin for removal, which is warmed before being returned to the body of the patient. Unlike in double-filtration plasma exchange, in the modified method, cryogels, which are complexes of immunoglobulins, fibrinogen, and other components, form when the plasma is cooled down, and the cause of the disease can be efficiently removed [11] . Taniyama et al. [12] reported four cases of mixed cryoglobulinemia where cryofiltration was used successfully. Among these four, three cases were HCV-associated cryoglobulinemia and one was essential mixed cryoglobulinemia, which had the complications of a nephrotic syndrome and acute kidney injury; the concurrent use of cryofiltration and an adrenocortical drug was very effective. Wada et al. [13] also used cryofiltration on a patient with essential mixed cryoglobulinemia with the complication of acute renal failure and they succeeded in freeing the patient from dialysis. To date, evidence on the effectiveness of cryofiltration in treating essential mixed cryoglobulinemia is still insufficient, but it has been reported to provide immediate relief to patients with severe clinical symptoms, similar to the present case. We need to continue accumulating evidence. With regard to immunosuppressant therapy for essential mixed cryoglobulinemia, the effectiveness of anti-B cell therapies (e.g., with rituximab), in addition to corticosteroids and cyclophosphamide, has also been reported recently [14, 15] . Cryoglobulin is produced as a result of genetic and environmental factors, additionally playing some role in the onset mechanism of cryoglobulinemia. For example, persistent infections, such as HCV, stimulate the proliferation of B-lymphocytes. Thus, anti-B-cell therapies are considered promising. MZR is a purine metabolism antagonist that was developed in Japan. In the body, it is metabolized to mizoribine-5′-phosphate, thus inhibiting inosine monophosphate dehydrogenase, a rate-limiting enzyme of the de novo purine biosynthesis pathway. This, in turn, inhibits the proliferation and activity of not only activated T-lymphocytes, but also B-lymphocytes [16] . Because of its anti-B-cell activity, MZR may potentially be effective for cryoglobulinemia. In fact, it has been shown in a report that the combination of Predonine with MZR yielded high effectiveness against skin purpura and ulcers caused by cryoglobulinemia [17] . In addition, the effectiveness of MZR against steroidresistant nephrotic syndromes [18] , like the present case, has been reported. Moreover, MZR has been reported to have an enhancing action on the effect of corticosteroid drugs. It was shown to act on the conformation of 14-3-3 proteins, affecting their binding with glucocorticoid receptors and enhancing the transcriptional activity of these receptors in a dose-dependent manner [19] . Therefore, MZR would be effective in steroid-resistant conditions. The advantages of MZR include the fact that it has relatively mild adverse effects on elderly patients and it can be used for a long time easily. The combination use of MZR has been successful also as a maintenance therapy after remission. Therefore, MZR needs further investigation as one of the immunosuppressant choices against essential cryoglobulinemia.
The complement activation system plays an important role in triggering cryoglobulin-induced MPGN. The complement system is constructed from three activation pathways: classical, alternative, and lectin pathways. Particularly, the classical pathway is associated with the progression of immunoglobulin-positive MPGN, such as cryoglobulinemic glomerulonephritis [20] .
Cryoglobulinemic glomerulonephritis includes low C4 levels in three quarters and low C3 levels in half [4] . With regard to hypocomplementemia, C3 is included as an item in the severity classification, and our patient responded to the treatment with an improvement in the C3 level, along with an improvement in proteinuria and other symptoms. The C3 level here probably reflects the status of the disease. However, the patient's C4 level remained low. The lowering of C4 is believed to be due to its excess consumption caused by the immunological response. This is often seen in patients with cryoglobulinemia [21, 22] . C4 is not always correlated with the severity of cryoglobulinemic vasculitis [23] , and the low C4 level in our patient also did not seem to reflect the severity of the disease.
Conclusion
In the present case, we could achieve long-term complete remission of steroid-resistant MPGN caused by essential cryoglobulinemia by a combination therapy of MZR and cryofiltration in addition to a steroid. An immediate effect could be achieved in this severe case by cryofiltration in the early stage of treatment.
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